Page last updated: 2024-11-01

ondansetron and Anoxemia

ondansetron has been researched along with Anoxemia in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamendi, HW2
Cheng, Q2
Dergacheva, O2
Gorini, C2
Jameson, HS2
Wang, X2
McIntosh, JM1
Mendelowitz, D2
Frank, JG1
Pinol, RA1

Other Studies

2 other studies available for ondansetron and Anoxemia

ArticleYear
Abolishment of serotonergic neurotransmission to cardiac vagal neurons during and after hypoxia and hypercapnia with prenatal nicotine exposure.
    Journal of neurophysiology, 2009, Volume: 101, Issue:3

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Animals, Newborn; Conotoxins; Dose

2009
Recruitment of excitatory serotonergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus post hypoxia and hypercapnia.
    Journal of neurophysiology, 2008, Volume: 99, Issue:3

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenosine Triphosphate; Animals; Animals, Newborn; Drug Intera

2008